BARNES & NOBLE EDUCATION INC (BNED)

US06777U2006 - Common Stock

11.35  -0.31 (-2.66%)

After market: 11.35 0 (0%)

Fundamental Rating

2

Taking everything into account, BNED scores 2 out of 10 in our fundamental rating. BNED was compared to 122 industry peers in the Specialty Retail industry. Both the profitability and financial health of BNED have multiple concerns. BNED has a valuation in line with the averages, but on the other hand it scores bad on growth.



1

1. Profitability

1.1 Basic Checks

BNED had positive earnings in the past year.
In the past year BNED has reported a negative cash flow from operations.
BNED had negative earnings in each of the past 5 years.
In multiple years BNED reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -11.17%, BNED is not doing good in the industry: 76.03% of the companies in the same industry are doing better.
With a Return On Equity value of -77.77%, BNED is not doing good in the industry: 74.38% of the companies in the same industry are doing better.
BNED has a Return On Invested Capital (1.36%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -11.17%
ROE -77.77%
ROIC 1.36%
ROA(3y)-7.93%
ROA(5y)-8.13%
ROE(3y)-65.88%
ROE(5y)-50.9%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BNED's Operating Margin of 0.57% is in line compared to the rest of the industry. BNED outperforms 41.32% of its industry peers.
BNED's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 22.56%, BNED is not doing good in the industry: 77.69% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BNED has declined.
Industry RankSector Rank
OM 0.57%
PM (TTM) N/A
GM 22.56%
OM growth 3YN/A
OM growth 5Y-30.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.61%
GM growth 5Y-2.57%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BNED is destroying value.
The number of shares outstanding for BNED has been reduced compared to 1 year ago.
Compared to 5 years ago, BNED has less shares outstanding
BNED has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.89, we must say that BNED is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.89, BNED is doing worse than 74.38% of the companies in the same industry.
A Debt/Equity ratio of 1.54 is on the high side and indicates that BNED has dependencies on debt financing.
With a Debt to Equity ratio value of 1.54, BNED is not doing good in the industry: 62.81% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Altman-Z 0.89
ROIC/WACC0.11
WACC11.96%

2.3 Liquidity

BNED has a Current Ratio of 1.23. This is a normal value and indicates that BNED is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.23, BNED perfoms like the industry average, outperforming 42.98% of the companies in the same industry.
BNED has a Quick Ratio of 1.23. This is a bad value and indicates that BNED is not financially healthy enough and could expect problems in meeting its short term obligations.
BNED has a worse Quick ratio (0.40) than 62.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.4

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 106.67% over the past year.
The Revenue has been growing slightly by 1.48% in the past year.
BNED shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.09% yearly.
EPS 1Y (TTM)106.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.33%
Revenue 1Y (TTM)1.48%
Revenue growth 3Y3.67%
Revenue growth 5Y-5.09%
Sales Q2Q%-0.28%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y51.76%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.29%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

BNED is valuated cheaply with a Price/Earnings ratio of 1.09.
BNED's Price/Earnings ratio is rather cheap when compared to the industry. BNED is cheaper than 100.00% of the companies in the same industry.
BNED is valuated cheaply when we compare the Price/Earnings ratio to 27.83, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for BNED. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 1.09
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BNED is valued a bit cheaper than 61.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.19

4.3 Compensation for Growth

BNED's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BNED!.
Industry RankSector Rank
Dividend Yield N/A

BARNES & NOBLE EDUCATION INC

NYSE:BNED (12/18/2024, 7:00:00 PM)

After market: 11.35 0 (0%)

11.35

-0.31 (-2.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap309.74M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 1.09
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.17%
ROE -77.77%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.57%
PM (TTM) N/A
GM 22.56%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.56
Health
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.23
Quick Ratio 0.4
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)106.67%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y51.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.48%
Revenue growth 3Y3.67%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y